Format

Send to

Choose Destination
Leukemia. 2014 May;28(5):1163-7. doi: 10.1038/leu.2014.12. Epub 2014 Jan 10.

B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies.

Author information

1
Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland.
2
Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
3
International Centre for Genetic Engineering and Biotechnology, Molecular Hematology Group, Campus A. Buzzati-Traverso, Rome, Italy.
4
IBiSA Cancer Immunomonitoring Platform, Institut Paoli Calmettes, UM 105, Aix-Marseille Université, Marseille, France.
5
1] Department of Immunology, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland [2] Department 3, Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland.
PMID:
24492323
DOI:
10.1038/leu.2014.12
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center